Deletion of STX1B decreases the size of RRP in glutamatergic and GABAergic synapses. by Tatsuya Mishima (529071)

“…<p>(A) Average EPSC evoked by application of 0.5 M hypertonic sucrose solution for 15 s in WT and STX1B^−/− neurons (left). …”

AZA decreased AQP1protein content by promoting AQP1 degradation. by Jianzhao Zhang (133200)

Survival and average length of <i>Cesmn-1(lf)</i> animals is decreased. by Maria Dimitriadi (238530)

SN09-2 decreases mitochondrial membrane potential and induces ROS generation. by Sumi Park (420314)

Gefitinib and erlotinib decreased cyclin-D1 without activation of caspase-3. by Satoshi Koyama (784927)

IFN-γ decreased viability of melanocytes, caused apoptosis and cell cycle arrest. by Suiquan Wang (544573)

Combination of cAMP-enhancing and cAMP-inhibiting neuromodulation can increase or decrease the AP threshold throughout the apical dendrite in the Hay-model L5PC. by Tuomo Mäki-Marttunen (388882)

Expression levels of GDE, and activity of GP and PKA are decreased during ischemic stroke. by Mohammed Iqbal Hossain (568166)

TG6-44 treatment leads to a decrease in NP-positive cells and altered expression patterns of NP in A/X31 infected THP-1 cells. by Juan A. De La Cruz (11154187)

Variability is correlated with increasing repeat length, increasing purity, and decreasing unit size. by John W. Fondon III (145820)

TNFα decreases cell NO, and reversal of this effect by adenosine is eNOS-dependent. by Theodore J. Kalogeris (575591)

Dynamin inhibition decreases apoE secretion from primary human macrophages. by Maaike Kockx (154125)

A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

“…<p>Hippocampal neurons in culture (DIV 12–13) were briefly exposed to 5 µM glutamate, immediately treated with fPSA and evaluated 3 and 6 h later. …”

Loss of Vps34 is associated with decreased eTreg survival but intact activation. by Erienne G. Norton (9612079)

Decreased FA number and size in Rgnef−/− MEFs on fibronectin (FN) at 120 min. by Nichol L. G. Miller (162752)

Treatment with con-G showed improved neurological scoring and decreased peri-infarct Ca²⁺ microdeposits. by Rashna Balsara (714796)

Mechanical acupuncture by MAI decreases cocaine-induced locomotor activity in a stimulus time-dependent manner. by Seol Ah Kim (486416)

URBAN FOREST COMPONENTS INFLUENCING MICROCLIMATE AND COOLING POTENTIAL1 by Angeline Martini (4699567)

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”